![Frontiers | The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies | Immunology Frontiers | The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies | Immunology](https://www.frontiersin.org/files/Articles/533888/fimmu-11-00784-HTML/image_m/fimmu-11-00784-g001.jpg)
Frontiers | The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies | Immunology
![Frontiers | PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome | Pharmacology Frontiers | PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome | Pharmacology](https://www.frontiersin.org/files/Articles/273409/fphar-08-00561-HTML/image_m/fphar-08-00561-g001.jpg)
Frontiers | PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome | Pharmacology
![IJMS | Free Full-Text | The Evolving Role of CD8+CD28− Immunosenescent T Cells in Cancer Immunology | HTML IJMS | Free Full-Text | The Evolving Role of CD8+CD28− Immunosenescent T Cells in Cancer Immunology | HTML](https://www.mdpi.com/ijms/ijms-20-02810/article_deploy/html/images/ijms-20-02810-g001.png)